Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2025 Aug 21;13(9):e70775. doi: 10.1002/ccr3.70775

Pruritic Plaque on the Right Lower Limb: A Rare Case of Kimura Disease and Literature Review

Xiaoxiao Liu 1, Xiaolan Zhang 1,✉
PMCID: PMC12370539  PMID: 40860296

ABSTRACT

Kimura disease, though rare in adolescents, should be considered in cases of persistent itchy nodules. Histopathology confirms diagnosis. Surgical excision is effective for localized lesions, with favorable outcomes. Early recognition prevents misdiagnosis and unnecessary treatments.

Keywords: adolescent case, clinical diagnosis, eosinophilic lymphogranuloma, Kimura disease, pruritic plaque, urticaria pigmentosa

1. Introduction

Kimura disease (KD) is an uncommon benign lymphoproliferative disorder with an elusive etiology. It is most commonly observed in young adult males between the ages of 20 and 40 years, with a predilection for the head, neck, and extremities, often accompanied by regional lymph node enlargement and occasional involvement of the parotid and mandibular glands. The characteristics of lesions are typically non‐tender masses, which may also lead to the appearance of prurigo‐like nodules. While most patients exhibit no symptoms, a few may experience episodes of intense itching. Here, we present a case of a 16‐year‐old girl who sought medical attention at our hospital because of an itchy plaque on her right lower limb. Owing to the patient's non‐specific clinical signs, a series of routine blood tests and local histopathological examinations were conducted, culminating in a definitive diagnosis of KD. This case report underscores the exceptional presentation of KD solely as pruritic plaques and the importance of considering KD in the differential diagnosis alongside conditions such as pigmentary urticaria, dermatofibroma, and angiolymphoid hyperplasia with eosinophilia.

2. Case History/Examination

A 16‐year‐old girl presented with a 3‐month history of two brown, bean‐sized itchy plaques on her right lower limb (Figure 1). Initially, the rashes appeared as red patches on the inner aspect of the right thigh without an identifiable cause. The patient's persistent itching led to frequent scratching, which caused the lesions to expand and their color to deepen. Notably, the patient did not exhibit fever, joint swelling, pain, fatigue, or other related symptoms, and no history of hospitalization or familial predisposition was reported. Physical examination revealed two bean‐sized brown nodules on the inner side of the right thigh.

FIGURE 1.

FIGURE 1

Photograph of the patient's right lower limb.

3. Differential Diagnosis, Investigations and Treatment

The complement blood count and serum biochemical examination results were normal; chest CT did not show any abnormalities.

Given the non‐specific clinical presentation and atypical lesion location, several differential diagnoses were initially considered. These included pigmentary urticaria, which can present as pruritic hyperpigmented plaques; dermatofibroma, a benign dermal nodule common in adolescents; and angiolymphoid hyperplasia with eosinophilia (ALHE), which may share clinical and histologic features with Kimura disease, but is distinguished by prominent vascular proliferation with epithelioid endothelial cells.

To establish a definitive diagnosis, an incisional biopsy of the leg nodules was performed. Histological findings revealed a dense infiltration of lymphocytes and scattered eosinophils throughout the dermis, along with lymphoid follicle‐like structures and mild small‐vessel hyperplasia in the deeper dermis (Figure 2). Based on these findings, the patient's clinical presentation, histological findings, and final diagnosis of Kimura disease (KD) were established.

FIGURE 2.

FIGURE 2

The pathological characteristics of lower extremity lesions. (A–C) The epidermis shows no significant abnormalities, while notable infiltration of lymphocytes and eosinophils is observed in the dermis. (D, E) Lymphoid follicular‐like structures and dilated small blood vessels are also present. (A: SP × 40; B: SP × 200; C: SP × 400; D: SP × 200; E: SP × 400; hematoxylin and eosin staining)

Given the localized nature of the patient's condition, surgical excision of the lesions was selected as the treatment approach.

4. Outcome and Follow‐Up

After 3 months of follow‐up, no recurrence was observed.

5. Discussion

KD, also known as eosinophilic lymphogranuloma, is a rare chronic inflammatory condition. Its pathogenesis remains unclear, although it may be related to the proliferative responses induced by atopic hypersensitivity and chronic infection. Recently, Wu et al. [1]. explored the immunopathogenesis of KD through multi‐omics studies and identified excessive activation of the MAPK signaling pathway in eosinophils derived from KD, suggesting that the ERK/MAPK pathway is a potential pathogenic factor in KD.

Regarding clinical characteristics, we reviewed 43 case reports involving 77 patients [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44] as detailed in Table 1. Our findings indicate that most KD cases occurred in Asia, particularly in China, Japan, and Southeast Asian countries, with a higher prevalence among young to middle‐aged males. The male‐to‐female ratios ranged from 3.5:1 to 9:1 [45]. In another study of 29 Chinese pediatric patients, the gender ratio was 28:1, with a median age of 12 years (range, 2.7–18 years) [46] at diagnosis; whereas in our case series, it was 30 years (range, 4–81 years). However, the sex ratio was 3.3:1, which may be attributed to the small sample size.

TABLE 1.

Features of 77 patients with Kimura disease.

Characteristics No. of patients (%)
Sex Male 59 (76.6%)
Female 18 (23.4%)
Age (Years) < 35 42 (54.5%)
≥ 35 35 (45.5%)
Race Asian 67 (87.0%)
Black 5 (6.5%)
White 3 (3.9%)
Not reported 2 (2.6%)
Body site affected Head and neck 61 (79.2%)
Non‐head and neck 9 (11.7%)
Extremities 5 (6.5%)
Trunk 2 (2.6%)
Peripheral blood eosinophil percentages Elevated 60 (77.9%)
Normal 17 (22.1%)
IgE level in peripheral blood Elevated 39 (50.6%)
Normal 38 (49.4%)
Histopathology findings Significant lymphoid follicle formation 54 (70.1%)
Active germinal centers and deposits of eosinophilic substances 36 (46.8%)
Eosinophilic infiltration 77 (100%)
Eosinophilic microabscess 26 (33.8%)
Small vessel hyperplasia and fibrous tissue hyperplasia 38 (49.4%)
Clinical management SE 31 (40.3%)
SE + OC 12 (15.6%)
SE + R 2 (2.6%)
OC + ISD 7 (9.1%)
Biotherapy 2 (2.6%)
Comorbidities Anaphylactic disease 5 (6.5%)
Systemic mastocytosis and polycythemia vera 1 (1.3%)
IgG4‐RD 2 (2.6%)
Rheumatoid arthritis 1 (1.3%)
Vascular lymphoid hyperplasia with eosinophilia 1 (1.3%)
Nephrotic syndrome 4 (5.2%)
Budd–Chiari syndrome 1 (1.3%)
Rubinstein–Taybi syndrome 1 (1.3%)

Abbreviations: OC + ISD, oral corticosteroids and immunosuppressive drug; SE, surgical resection alone, surgical resection followed by oral corticosteroids; SE + R, surgical resection combined with radiotherapy.

KD is insidious at its onset and has a long clinical course. In our case review, KD lesions were predominantly located in the head and neck region (79.2%), particularly in the parotid gland, salivary glands, and lymph nodes [24, 30, 32]. Other affected regions included non‐head‐and‐neck areas (11.7%), such as the inguinal region, retroperitoneum, and mediastinum, as well as the extremities (6.5%) and trunk (2.6%). The primary manifestation is a painless subcutaneous mass in the head and neck region. Most patients were asymptomatic; although intense pruritus can occur and worsen with age [47]. Some patients present with early renal or bone invasion. Previous studies have also reported clinical presentations such as earlobe keloids [25], destructive bone lesions associated with soft tissue masses [29], or involvement of multiple lymph nodes across various regions [18]. Additionally, some patients exhibited comorbidities such as asthma, allergic rhinitis, urticaria (6.5%), nephrotic syndrome (5.2%), vasculitis, cutaneous amyloidosis, and juvenile temporal arteritis [48].

Peripheral blood eosinophilia (77.9%) and elevated IgE levels (50.6%) are commonly observed in KD, aiding in its diagnosis. Computed tomography (CT) and magnetic resonance imaging (MRI) are essential tools for evaluating specific cases [44, 49, 50], allowing the determination of the location, size, margins, and blood supply of the masses, as well as systemic lymph node involvement [50, 51]. The characteristic CT and MRI findings in head and neck KD include multiple ill‐defined enhancing masses within and around the parotid gland [50], accompanied by regional lymphadenopathy. Therefore, radiography plays a supplementary role in the diagnosis of KD.

KD progresses slowly and is often misdiagnosed because of the lack of overt clinical symptoms. Unlike in previous reports, our patient did not present with common painless masses or lymph node involvement. Instead, the patient exhibited two pea‐sized, dark brown, infiltrated plaques on the inner side of the right thigh, a rare dermatologic manifestation. Laboratory tests failed to provide specific positive results, initially leading to a presumptive diagnosis of urticaria pigmentosa based on the patient's history and related laboratory findings. However, histopathological examination confirmed the diagnosis of KD. This case highlights the importance of recognizing uncommon clinical presentations to improve diagnostic accuracy.

Histopathological examination remains the gold standard for diagnosing KD. Our review of 77 cases revealed the following typical pathological features: significant lymphoid follicle formation (70.1%), active germinal centers with eosinophilic material deposits (46.8%), eosinophilic infiltration (100%), eosinophilic microabscess formation (33.8%), and small vessel proliferation with fibrosis (49.4%). Consistent with previous studies, our patient's pathology showed dense lymphocytic infiltration throughout the dermis, scattered eosinophilic infiltration, lymphoid follicle‐like structures in deeper tissues, mild small vessel proliferation, and no epidermal abnormalities, all of which were consistent with the pathology of KD.

The patient's skin lesion, which was a pruritic brownish plaque on the lower extremity, closely resembled the typical presentation of urticaria pigmentosa. Clinically, differentiating these two conditions solely based on skin lesions is challenging. However, histopathological changes in urticaria pigmentosa include mast cell infiltration in the dermal papillae with metachromatic granules observable via Giemsa staining, which were absent in our case, ruling out urticaria pigmentosa. The primary differential diagnosis is angiolymphoid hyperplasia with eosinophilia (ALHE). ALHE is commonly observed in middle‐aged Western females and presents as pale‐red to reddish‐brown papules without lymph node or parotid gland involvement. In contrast, KD is more common in young Asian males and presents as subcutaneous nodules or masses with overlying skin of normal color, often involving the regional lymph nodes and salivary glands. Histopathologically, ALHE is characterized by vascular proliferation with varying degrees of eosinophilic and lymphocytic infiltration around the vessels, lack of eosinophilic microabscesses, germinal centers, and significant fibrosis, which are prominent features of KD [52, 53, 54]. Eosinophilic granuloma is a granulomatous condition characterized by the presence of eosinophils, plasma cells, lymphocytes, and fibrotic tissue. It commonly affects the skin, bones, and other organs. Clinically, it typically presents as localized erythematous patches, nodules, or masses, often accompanied by local discomfort or pain. Although eosinophilic granuloma may resemble the brownish plaques observed in the current case, histopathological features allow for clear differentiation. In our case, skin biopsy revealed dense dermal infiltration of lymphocytes and scattered eosinophils, but no well‐formed granulomatous structures were observed. In contrast, eosinophilic granuloma typically exhibits characteristic granulomas with central necrosis and a more prominent eosinophilic infiltrate. Therefore, despite some clinical overlap, the histopathological findings in this case do not support a diagnosis of eosinophilic granuloma.

Castleman disease is a rare lymphoproliferative disorder that is classified into unicentric and multicentric forms based on clinical presentation. Unicentric Castleman disease usually manifests as isolated lymphadenopathy and is often asymptomatic systemically, although localized skin nodules or masses may occasionally be present. Histologically, it is characterized by prominent lymphoid follicular hyperplasia, vascular proliferation, and varying degrees of plasma cell infiltration. In the present case, the patient exhibited no lymphadenopathy or systemic symptoms, and the skin lesions were confined to the inner aspect of the right thigh. Histopathological examination revealed dense lymphocytic infiltration with scattered eosinophils, follicle‐like lymphoid structures, and mild small‐vessel proliferation, without the typical architectural features of Castleman disease. These findings are more consistent with Kimura disease.

There are currently no standardized guidelines for the treatment of KD. A review of previous case reports revealed various treatment modalities, including surgery alone (40.3%), surgery combined with oral corticosteroids (15.6%), surgery combined with local radiotherapy (2.6%), oral corticosteroids combined with immunosuppressants (9.1%), and biologics (2.6%). Oral corticosteroids are the mainstay of pharmacotherapy for this disease, although some patients experience relapse after discontinuation. Owing to its notable side effects, radiotherapy is not recommended for lesions in critical areas such as the orbit and extraocular muscles. Therefore, treatment plans should be individualized, and novel therapeutic approaches should be explored. Yang et al. successfully treated a patient with KD and painless masses around the auricular regions using dupilumab. Kinoshita et al. reported that monotherapy with 300 mg of mepolizumab led to the resolution of clinical symptoms in a patient with KD, with early intervention potentially preventing secondary fibrosis. Given the limited number of KD cases and predominance of case reports in clinical studies, the optimal treatment strategy for KD remains unclear. Given the localized nature of the lesion in our patient and absence of pruritus or other discomfort, surgery was selected. The patient was followed up for 3 months postoperatively without signs of recurrence.

Author Contributions

Xiaoxiao Liu: visualization, writing – original draft. Xiaolan Zhang: resources, supervision, writing – review and editing.

Consent

Written informed consent was obtained from the patient's legal guardian to publish this case report and any accompanying images in accordance with the journal's patient consent policy.

Conflicts of Interest

The authors declare no conflicts of interest.

Liu X. and Zhang X., “Pruritic Plaque on the Right Lower Limb: A Rare Case of Kimura Disease and Literature Review,” Clinical Case Reports 13, no. 9 (2025): e70775, 10.1002/ccr3.70775.

Funding: The authors received no specific funding for this work.

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

References

  • 1. Wu X., Wang A., Zhang S., et al., “Multiomic Landscape of Immune Pathogenesis in Kimura's Disease,” IScience 26, no. 4 (2023): 106559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Buggage R. R., Spraul C. W., Wojno T. H., and Grossniklaus H. E., “Kimura Disease of the Orbit and Ocular Adnexa,” Survey of Ophthalmology 44, no. 1 (1999): 79–91. [DOI] [PubMed] [Google Scholar]
  • 3. Watanabe C., Koga M., Honda Y., and Oh‐I T., “Juvenile Temporal Arteritis Is a Manifestation of Kimura Disease,” American journal of dermatopathology 24, no. 1 (2002): 43–49. [DOI] [PubMed] [Google Scholar]
  • 4. Kanny G., Cogan E., Marie B., Schandene L., and Moneret‐Vautrin D. A., “A Case of Kimura Disease Treated With Interferon and General Corticoid Therapy,” La Revue de Médecine Interne 20, no. 6 (1999): 522–526. [DOI] [PubMed] [Google Scholar]
  • 5. Kim B. H., Sithian N., and Cucolo G. F., “Subcutaneous Angiolymphoid Hyperplasia (Kimura Disease). Report of a Case,” Archives of Surgery 110, no. 10 (1975): 1246–1248. [DOI] [PubMed] [Google Scholar]
  • 6. Nakahara C., Wada T., Kusakari J., et al., “Steroid‐Sensitive Nephrotic Syndrome Associated With Kimura Disease,” Pediatric Nephrology 14, no. 6 (2000): 482–485. [DOI] [PubMed] [Google Scholar]
  • 7. Kim C. J., Nam J. H., Chung H. Y., Kook J. H., Kim S. Y., and Woo Y. J., “Kimura Disease in a Patient With Rubinstein‐Taybi Syndrome,” Pediatrics International 46, no. 5 (2004): 609–611. [DOI] [PubMed] [Google Scholar]
  • 8. Yoganathan P., Meyer D. R., and Farber M. G., “Bilateral Lacrimal Gland Involvement With Kimura Disease in an African American Male,” Archives of Ophthalmology 122, no. 6 (2004): 917–919. [DOI] [PubMed] [Google Scholar]
  • 9. Lu H. J., Tsai J. D., Sheu J. C., et al., “Kimura Disease in a Patient With Renal Allograft Failure Secondary to Chronic Rejection,” Pediatric Nephrology 18, no. 10 (2003): 1069–1072. [DOI] [PubMed] [Google Scholar]
  • 10. Rajpoot D. K., Pahl M., and Clark J., “Nephrotic Syndrome Associated With Kimura Disease,” Pediatric Nephrology 14, no. 6 (2000): 486–488. [DOI] [PubMed] [Google Scholar]
  • 11. Uthgenannt D., Steinhoff J., Baretton G., and Sack K., “Kimura Disease With Minimally Proliferative Glomerulonephritis,” Deutsche Medizinische Wochenschrift 116, no. 24 (1991): 935–938. [DOI] [PubMed] [Google Scholar]
  • 12. Ginsberg L. E. and McBride J. A., “Kimura's Disease,” American Journal of Roentgenology 171, no. 6 (1998): 1508. [DOI] [PubMed] [Google Scholar]
  • 13. Pamaraju N., Khalifa S. A., Darwish A., Paulose K. O., Ahmed N., and Yousif H., “Kimura's Disease,” Journal of Laryngology and Otology 110, no. 11 (1996): 1084–1087. [DOI] [PubMed] [Google Scholar]
  • 14. Biradar A., Patil A. V., Kotennavar M. S., and Venkatachalaiah M., “Kimura's Disease: A Case Report,” Indian Journal of Surgery 75, no. Suppl 1 (2013): 430–431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Chopinaud M., Morice C., Comoz F., et al., “An Atypical Form of Kimura's Disease,” Annales de Dermatologie et de Venereologie 140, no. 11 (2013): 699–703. [DOI] [PubMed] [Google Scholar]
  • 16. Lee C. C., Yu K. H., and Chan T. M., “Kimura's Disease: A Clinicopathological Study of 23 Cases,” Front Med‐Lausanne 9 (2022): 1069102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Yang B., Yu H., Jia M., et al., “Successful Treatment of Dupilumab in Kimura Disease Independent of IgE: A Case Report With Literature Review,” Frontiers in Immunology 13 (2022): 1084879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Yu B., Xu G., Liu X., Yin W., Chen H., and Sun B., “Kimura's Disease Affecting Multiple Body Parts in a 57‐Year‐Old Female Patient: A Case Report,” Allergy, Asthma & Clinical Immunology 15 (2019): 84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Hobeika C. M., Mohammed T. L., Johnson G. L., and Hansen K., “Kimura's Disease: Case Report and Review of the Literature,” Journal of Thoracic Imaging 20, no. 4 (2005): 298–300. [DOI] [PubMed] [Google Scholar]
  • 20. Chong W. S., Thomas A., and Goh C. L., “Kimura's Disease and Angiolymphoid Hyperplasia With Eosinophilia: Two Disease Entities in the Same Patient: Case Report and Review of the Literature,” International Journal of Dermatology 45, no. 2 (2006): 139–145. [DOI] [PubMed] [Google Scholar]
  • 21. Kumar V., Mittal N., Huang Y., et al., “A Case Series of Kimura's Disease: A Diagnostic Challenge,” Therapeutic Advances in Hematology 9, no. 7 (2018): 207–211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Shetty A. K., Beaty M. W., McGuirt W. J., Woods C. R., and Givner L. B., “Kimura's Disease: A Diagnostic Challenge,” Pediatrics 110, no. 3 (2002): e39. [DOI] [PubMed] [Google Scholar]
  • 23. Hu X., Li X., Yang C., Li D., Cai J., and Wang P., “Kimura Disease, a Rare Cause of Inguinal Lymphadenopathy: A Case Report,” Frontiers in Medicine 9 (2022): 1023804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Parikh S., Sharma S., and Shah J. S., “Kimura's Disease: A Confounding Condition,” Indian Journal of Otolaryngology 74, no. Suppl 3 (2022): 5342–5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Yeh S. W., Lee W. R., Hu C. H., and Tsai H. H., “Kimura's Disease Mimicking an Earlobe Keloid,” Clinical and Experimental Dermatology 35, no. 4 (2010): e97–e99. [DOI] [PubMed] [Google Scholar]
  • 26. Han Q., Han J., Wang W., et al., “Case Report: Kimura's Disease With Minimal Degenerative Glomerulopathy Without Eosinophil Infiltration Responds to Mycophenolate Mofetil Treatment,” Frontiers in Medicine 9 (2022): 1069553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Zhou P., Zhang W., Shi W., and Zhang Y., “Kimura Disease,” Dermatology Online Journal 23, no. 10 (2017): 1–3. [PubMed] [Google Scholar]
  • 28. Kuroda K., Kashiwagi S., Teraoka H., et al., “Kimura's Disease Affecting the Axillary Lymph Nodes: A Case Report,” BMC Surgery 17, no. 1 (2017): 63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Chung Y. G., Jee W. H., Kang Y. K., et al., “Kimura's Disease Involving a Long Bone,” Skeletal Radiology 39, no. 5 (2010): 495–500. [DOI] [PubMed] [Google Scholar]
  • 30. Meningaud J. P., Pitak‐Arnnop P., Fouret P., and Bertrand J. C., “Kimura's Disease of the Parotid Region: Report of 2 Cases and Review of the Literature,” Journal of Oral and Maxillofacial Surgery 65, no. 1 (2007): 134–140. [DOI] [PubMed] [Google Scholar]
  • 31. Luo G., Gu F., Liu T., and Huang Y., “Kimura's Disease of the Right Cheek: A Case Report,” Experimental and Therapeutic Medicine 11, no. 1 (2016): 218–220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Chen J. L., Wang Q., Huang L. M., et al., “A Rare Case of Kimura Disease With Lumps on the Cheek and Behind the Ear,” Oral Oncology 121 (2021): 105303. [DOI] [PubMed] [Google Scholar]
  • 33. Sugimoto K., Enya T., Morimoto Y., Oshima R., Miyazaki K., and Okada M., “Kimura's Disease With Recurrent Bilateral Lacrimal Gland Involvement in a Male Japanese Child Successfully Treated With Cyclosporine A,” Allergy, Asthma & Clinical Immunology 17, no. 1 (2021): 48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Mai Y., Wang Y., Sun P., Jing Z., Dong P., and Liu J., “Kimura Disease in Children: A Report of 11 Cases and Review of the Literature,” Frontiers in Pediatrics 11 (2023): 1131963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Yang B., Liao H., Wang M., et al., “Kimura's Disease Successively Affecting Multiple Body Parts: A Case‐Based Literature Review,” BMC Ophthalmology 22, no. 1 (2022): 154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Huang G. S., Lee H. S., Chiu Y. C., Yu C. C., and Chen C. Y., “Kimura's Disease of the Elbows,” Skeletal Radiology 34, no. 9 (2005): 555–558. [DOI] [PubMed] [Google Scholar]
  • 37. Ramachandran P. V., Healy C. M., Lambert E. M., Guerra D., Curry C. V., and Vogel T. P., “Case Report: Hyper IgE, but Not the Usual Suspects‐Kimura Disease in an Adolescent Female,” Frontiers in Pediatrics 9 (2021): 674317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Wang T., Mei Y. J., and Li Z. J., “Kimura Disease With a History of Budd‐Chiari Syndrome: A Case Report,” Chinese Medical Journal 133, no. 19 (2020): 2392–2394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Xie F., Kou Y., Zhang S., Shi L., Han J., and Zhou X., “Bilateral Posterior Auricular Masses: A Case of Kimura's Disease,” Ear, Nose & Throat Journal 100, no. 9 (2021): 634–637. [DOI] [PubMed] [Google Scholar]
  • 40. Kinoshita M., Ogawa Y., Onaka M., Shimada S., and Kawamura T., “Mepolizumab‐Responsive Kimura disease,” Journal of Allergy and Clinical Immunology. In Practice 9, no. 7 (2021): 2928–2930. [DOI] [PubMed] [Google Scholar]
  • 41. Liu Y., Liu S., Xu J., Xu X., and Wang M., “An Unusual Case of Systemic Lymphadenopathy ‐ Kimura's Disease,” Journal of Inflammation Research 16 (2023): 701–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Yang T. H., Chou Y. H., Kao W. Y., and Cherng S. C., “Kimura Disease Simulating Hodgkin's Lymphoma on (18)F FDG PET‐CT: Report of a Case,” Nuclear Medicine and Molecular Imaging 48, no. 4 (2014): 313–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Hsu S. N., Chang C. F., Su T. F., Hsu Y. C., Chen Y. A., and Chen H. C., “Kimura's Disease Associated Necrotizing Eosinophilic Vasculitis Presenting With Recurrent Peripheral Arterial Occlusive Disease: A Case Report and Review of the Literature,” Journal of Thrombosis and Thrombolysis 39, no. 1 (2015): 144–147. [DOI] [PubMed] [Google Scholar]
  • 44. Braun J., Mairinger T., Kaschke O., Behrendt K., Ramsbacher J., and Karberg K., “Bilateral Swelling of the Salivary Glands and Sicca Symptoms: An Unusual Differential Diagnosis‐Kimura's Disease, a Rare Allergic Condition With a High IgE Serum Level‐a Case Report and Review of the Literature,” RMD Open 9, no. 2 (2023): e003135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Wang D. Y., Mao J. H., Zhang Y., et al., “Kimura Disease: A Case Report and Review of the Chinese Literature,” Nephron 111, no. 1 (2009): c55–c61. [DOI] [PubMed] [Google Scholar]
  • 46. Xu X., Fu J., Fang Y., and Liang L., “Kimura Disease in Children: A Case Report and a Summary of the Literature in Chinese,” Journal of Pediatric Hematology/Oncology 33, no. 4 (2011): 306–311. [DOI] [PubMed] [Google Scholar]
  • 47. Kakehi E., Kotani K., Otsuka Y., et al., “Kimura's Disease: Effects of Age on Clinical Presentation,” QJM: An International Journal of Medicine 113, no. 5 (2020): 336–345. [DOI] [PubMed] [Google Scholar]
  • 48. Ye P., Ma D. Q., Yu G. Y., Gao Y., and Peng X., “Comparison of the Efficacy of Different Treatment Modalities for Kimura's Disease,” International Journal of Oral and Maxillofacial Surgery 46, no. 3 (2017): 350–354. [DOI] [PubMed] [Google Scholar]
  • 49. Park J. S., Jin W., Ryu K. N., and Won K. Y., “Bilateral Asymmetric Superficial Soft Tissue Masses With Extensive Involvement of Both Upper Extremities: Demonstration of Kimura's Disease by US and MRI (2008: 12b),” European Radiology 19, no. 3 (2009): 781–786. [DOI] [PubMed] [Google Scholar]
  • 50. Choi J. A., Lee G. K., Kong K. Y., et al., “Imaging Findings of Kimura's Disease in the Soft Tissue of the Upper Extremity,” American Journal of Roentgenology 184, no. 1 (2005): 193–199. [DOI] [PubMed] [Google Scholar]
  • 51. Park S. W., Kim H. J., Sung K. J., Lee J. H., and Park I. S., “Kimura Disease: CT and MR Imaging Findings,” American Journal of Neuroradiology 33, no. 4 (2012): 784–788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Zou A., Hu M., and Niu B., “Comparison Between Kimura's Disease and Angiolymphoid Hyperplasia With Eosinophilia: Case Reports and Literature Review,” Journal of International Medical Research 49, no. 9 (2021): 675865392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Adler B. L., Krausz A. E., Minuti A., Silverberg J. I., and Lev‐Tov H., “Epidemiology and Treatment of Angiolymphoid Hyperplasia With Eosinophilia (ALHE): A Systematic Review,” Journal of the American Academy of Dermatology 74, no. 3 (2016): 506–512. [DOI] [PubMed] [Google Scholar]
  • 54. Buder K., Ruppert S., Trautmann A., Brocker E. B., Goebeler M., and Kerstan A., “Angiolymphoid Hyperplasia With Eosinophilia and Kimura's Disease‐A Clinical and Histopathological Comparison,” Journal Der Deutschen Dermatologischen Gesellschaft 12, no. 3 (2014): 224–228. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES